Impurose AC 75mg/10mg/75mg Capsule is a combination pharmaceutical formulation containing Aspirin (75mg), Rosuvastatin (10mg), and Clopidogrel (75mg), indicated for the prevention and management of cardiovascular diseases. Aspirin, a nonsteroidal anti-inflammatory drug with antiplatelet properties, inhibits cyclooxygenase enzymes, thereby reducing thromboxane A2 production and platelet aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) levels, contributing to the stabilization of atherosclerotic plaques and reduction of cardiovascular risk. Clopidogrel, an antiplatelet agent, irreversibly inhibits the P2Y12 component of ADP receptors on platelet surfaces, preventing platelet activation and aggregation. The combined action of these agents provides a synergistic effect in reducing the incidence of myocardial infarction, stroke, and other thrombotic events in patients with established atherosclerotic cardiovascular disease or those at high risk. Impurose AC is typically prescribed under medical supervision, with dosage and duration tailored to individual patient profiles. Caution is advised in patients with bleeding disorders, hepatic impairment, or hypersensitivity to any component. Regular monitoring of liver function, lipid profile, and hematological parameters is recommended to ensure safety and therapeutic efficacy.